AnaptysBio (ANAB) announced the appointment of Christopher Murphy as CFO and Owen Hughes as a member of its board of directors. Murphy previously served as CFO and CBO of Third Harmonic Bio.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANAB:
- AnaptysBio price target lowered to $93 from $95 at Piper Sandler
- AnaptysBio price target raised to $85 from $66 at Leerink
- GSK’s TESARO provides update on AnaptysBio litigation
- Joseph Thome Reiterates Buy on AnaptysBio as Royalty-Focused Model and Jemperli Legal Win Support $75 Price Target
- Delaware court dismisses Tesaro breach of contract claim against AnaptysBio